[1]
Castellani RJ, Perry G. The complexities of the pathology-pathogenesis relationship in Alzheimer disease. Biochem Pharmacol 2014; 88(4): 671-6.
[2]
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002; 297(5580): 353-6.
[3]
Heinitz MF. Magnesium and Alzheimer’s Disease: The Cholinergic Hypothesis. Schweizerische Zeitschrift Für Ganzheitsmedizin 2012; 24(6): 371-4.
[4]
Liu J, Ye X, Wu FX. Characterizing dynamic regulatory programs in mouse lung development and their potential association with tumourigenesis via miRNA-TF-mRNA circuits. BMC Syst Biol 2013; 7(Suppl. 2): S11.
[5]
Acquaah-Mensah GK, Taylor RC. Brain in situ hybridization maps as a source for reverse-engineering transcriptional regulatory networks: Alzheimer’s disease insights. Gene 2016; 586(1): 77-86.
[6]
Zhang L, Feng XK, Ng YK, Li SC. Reconstructing directed gene regulatory network by only gene expression data. BMC Genomics 2016; 17(Suppl. 4): 430.
[7]
Butter F, Davison L, Viturawong T, et al. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. PLoS Genet 2012; 8(9)e1002982
[8]
Ye C, Galbraith SJ, Liao JC, Eskin E. Using network component analysis to dissect regulatory networks mediated by transcription factors in yeast. PLOS Comput Biol 2009; 5(3)e1000311
[9]
Liao JC, Boscolo R, Yang YL, Tran LM, Sabatti C, Roychowdhury VP. Network component analysis: reconstruction of regulatory signals in biological systems. Proc Natl Acad Sci USA 2003; 100(26): 15522-7.
[10]
Chang C, Ding Z, Hung YS, Fung PC. Fast network component analysis (FastNCA) for gene regulatory network reconstruction from microarray data. Bioinformatics 2008; 24(11): 1349-58.
[11]
Sutherland GT, Janitz M, Kril JJ. Understanding the pathogenesis of Alzheimer’s disease: will RNA-Seq realize the promise of transcriptomics? J Neurochem 2011; 116(6): 937-46.
[12]
Warren AS, Aurrecoechea C, Brunk B, et al. RNA-Rocket: an RNA-Seq analysis resource for infectious disease research. Bioinformatics 2015; 31(9): 1496-8.
[13]
Li B, Tsoi LC, Swindell WR, et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol 2014; 134(7): 1828-38.
[14]
Wang R, Sun L, Bao L, et al. Bulk segregant RNA-seq reveals expression and positional candidate genes and allele-specific expression for disease resistance against enteric septicemia of catfish. BMC Genomics 2013; 14(1): 929.
[15]
Qi YX, Liu YB, Rong WH. RNA-Seq and its applications: a new technology for transcriptomics. Yi Chuan 2011; 33(11): 1191-202.
[16]
Soneson C, Delorenzi M. A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics 2013; 14(1): 91.
[17]
Oshlack A, Robinson MD, Young MD. From RNA-seq reads to differential expression results. Genome Biol 2010; 11(12): 220.
[18]
Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014; 15(2): R29.
[19]
Liang WS, Reiman EM, Valla J, et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 2008; 105(11): 4441-6.
[20]
Scheckel C, Drapeau E, Frias MA, et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. eLife 2016; 5: 5.
[21]
Chen HF, Wang JK. The databases of transcription factors. Yi Chuan 2010; 32(10): 1009-17.
[22]
Deng J, Kong W, Mou X, et al. Pathway Crosstalk Analysis based on Signaling Pathway Impact Analysis in Alzheimer’s Disease. Curr Proteomics 2018; 15(2): 142-50.
[23]
Caltagarone J, Jing Z, Bowser R. Focal adhesions regulate Abeta signaling and cell death in Alzheimer’s disease. Biochim Biophys Acta 2007; 1772(4): 438-45.
[24]
Arnold SE, Lee EB, Moberg PJ, et al. Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol 2010; 67(4): 462-9.
[25]
Liu Y, Jiancheng HE. Study and mechanism of expression of immune molecules in Alzheimer. J Apoplexy Nervous Dis 2002; 19(6): 378-80.
[26]
Ho AW, Garg AV, Monin L, Simpson-Abelson MR, Kinner L, Gaffen SL. The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction. PLoS One 2013; 8(7)e70168
[27]
Latchman DS. Transcription factors: an overview. Int J Exp Pathol 1993; 74(5): 417-22.
[28]
Li C. Alzheimer’s disease and signal transduction. Chem Life 2000; 20(6): 278-81.
[29]
Lukiw WJ. NF-κB-regulated, proinflammatory miRNAs in Alzheimer’s disease. Alzheimers Res Ther 2012; 4(6): 47.
[30]
Silva ART, Santos ACF, Farfel JM, et al. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer’s disease. PLoS One 2014; 9(6)e99897
[31]
Pascall JC, Lyons V, Curtis A, et al. Northern blot analysis of 7SL RNA indicates increased RNA degradation in Alzheimer’s disease. Biochem Soc Trans 1986; 14(1): 104-5.
[32]
Chen S, Ge X, Chen Y, Lv N, Liu Z, Yuan W. Advances with RNA interference in Alzheimer’s disease research. Drug Des Devel Ther 2013; 7(3): 117-25.
